EP0397635A1
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Peptide with anti-metastasis activity
Assignee: Monsanto Co
•
Filing: 1990-05-09
•
Granted: —
•
Expires: 2010-05-09
Abstract
Abstract The invention discloses an acylated pentapeptide that exhibits inhibitory activity toward malignant cell metastasis.
Inventors
- 👤 Charles Steven Schasteen
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-10-23 14:54
CPC Classifications
C; C07; C07K; C07K7/00; C07K7/04; C07K7/06; A; A61; A61P; A61P35/00; C07K14/00; C07K14/435; C07K14/78; A61K; A61K38/00
Claims Analysis
Total Claims: 15
Claim 1
Independent Claim
12 words
A peptide of the formula: AcYIGSR-NH₂, or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim
12 words
A peptide of the formula: AcYIGSR-NH₂, or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim
10 words
The peptide of Claim 1 of the formula: AcYIGSR-NH₂ .
Claim 4
Dependent Claim
19 words
The peptide of Claim 1 which is a pharmaceutically acceptable salt of the peptide of the formula: AcYIGSR-NH₂ .
Claim 5
Dependent Claim
26 words
A pharmaceutical composition comprising a pharmaceutically acceptable excipient and a therapeutically effective amount of a peptide of the formula: AcYIGSR-NH₂, or a pharmaceutically acceptable salt thereof.
Claim 6
Dependent Claim
26 words
A pharmaceutical composition comprising a pharmaceutically acceptable excipient and a therapeutically effective amount of a peptide of the formula: AcYIGSR-NH₂, or a pharmaceutically acceptable salt thereof.
Claim 7
Dependent Claim
16 words
The pharmaceutical composition of Claim 4 in which the peptide is of the formula: AcYIGSR-NH₂ .
Claim 8
Dependent Claim
23 words
The pharmaceutical composition of Claim 4 in which the peptide is a pharmaceutically acceptable salt of the peptide of the formula: AcYIGSR-NH₂ .
Claim 9
Independent Claim
24 words
A method for inhibiting metastasis which comprises administering an effective amount of a peptide of the formula: AcYIGSR-NH₂, or a pharmaceutically acceptable salt thereof.
Claim 10
Independent Claim
24 words
A method for inhibiting metastasis which comprises administering an effective amount of a peptide of the formula: AcYIGSR-NH₂, or a pharmaceutically acceptable salt thereof.
Claim 11
Dependent Claim
15 words
The method of Claim 7 in which the peptide is of the formula: AcYIGSR-NH₂ .
Claim 12
Dependent Claim
22 words
The method of Claim 7 in which the peptide is a pharmaceutically acceptable salt of the peptide of the formula: AcYIGSR-NH₂ .
Claim 13
Dependent Claim
20 words
The method of Claim 7 in which the peptide is administered as a pharmaceutical composition comprising a pharmaceutically acceptable excipient.
Claim 14
Dependent Claim
18 words
The method of Claim 10 in which the pharmaceutical composition comprises a peptide of the formula: AcYIGSR-NH₂ .
Claim 15
Dependent Claim
23 words
The method of Claim 11 in which the pharmaceutical composition comprises a pharmaceutically acceptable salt of the peptide of the formula: AcYIGSR-NH₂ .
References Cited (Backward Citations)
US5066716A
Cited
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.